JellyFil Official Website › How JellyFil Works
How JellyFil WorksHow Does JellyFil Work? Three Pathways, Nine Extracts
The nine extracts on this panel act in three different places, and none of them acts alone.
Arginine and horny goat weed work on blood-vessel signalling. Ashwagandha and tribulus are sold on the stress and hormone side. Muira puama, maca, catuaba, green tea and 5 mg of caffeine make up the rest. All nine share 82 mg, which is the figure every claim on this page has to survive.
A mechanism says how an ingredient could act. A trial says whether it did, in whom, and at what amount. This page keeps the two apart.
The first JellyFil pathway: nitric oxide and the vessel wall
Arginine is the amino acid the body converts into nitric oxide, a short-lived signalling molecule that relaxes the smooth muscle lining blood vessels. When that muscle relaxes, the vessel widens and more blood moves through it. This is one of the best-mapped pathways in human physiology and it is not controversial.
What is worth knowing is the arithmetic. a pharmacokinetic comparison of the two amino acids gave healthy adults single oral doses of 3 g and 6 g of arginine and tracked what reached the bloodstream, and the review of blood-pressure work discusses amounts in the same range. Those are grams, and nine extracts here share 82 milligrams.
Horny goat weed acts at the other end of the same signal. Its marker compound icariin inhibits the enzyme that breaks down the messenger nitric oxide produces, which is the same target prescription tablets use. the 2010 laboratory study of icariin demonstrated that in cell culture and in rats, and a review of plant PDE-5 inhibitors places icariin among the plant constituents with measurable activity there.
The second JellyFil pathway: stress load and hormone signalling
Ashwagandha is an adaptogen, which in practice means a plant studied for its effect on the stress response rather than on one organ. It has the largest randomised literature of anything on this panel: a meta-analysis of stress and anxiety trials pooled trials using 240 mg to 600 mg a day of root extract and found measurable falls in stress and anxiety scores, and a 2026 meta-analysis of hormone outcomes examined the endocrine side directly.
Tribulus is sold on a similar story, and this is where the published answer is least ambiguous. A 2026 meta-analysis of randomised trials at roughly 750 mg to 1,500 mg a day found small and inconsistent effects on erectile-function scores and no reliable change in testosterone. The broader review of this product category reached the same conclusion.
The third JellyFil pathway: the tonics and the two small stimulants
Muira puama and catuaba are traditional Brazilian and Amazonian barks, and both reach this panel on tradition rather than on trials. Muira puama’s published record is animal work: a memory experiment in mice and a 2003 enzyme study of the root are rodent studies of memory and of an enzyme, not human studies of vitality. Catuaba’s own difficulty is stranger and more interesting: when commercial catuaba was analysed, the material sold under the name came from more than one botanical source.
Maca is the exception in this group. the 2002 randomised maca trial ran 1,500 mg and 3,000 mg a day for twelve weeks in healthy men and reported raised sexual desire with serum testosterone unchanged, which is a genuinely useful pair of findings. A later systematic review called the picture suggestive rather than settled.
Green tea extract and 5 mg of caffeine round the panel out, and both are among the three the advertising omits. Green tea catechins have their own randomised literature at a median near 400 mg a day; 5 mg of caffeine is about a twentieth of a cup of coffee.
What JellyFil cannot do, stated plainly
- It is not a treatment for erectile dysfunction. That is a medical condition and no dietary supplement may claim to treat one.
- It does not raise testosterone. The extract with that reputation here is tribulus, and the randomised record does not support it.
- It cannot deliver a trial-strength amount of any single extract, because nine of them share 82 mg.
- It does not replace sleep, weight, alcohol intake, blood pressure control or activity, several of which have randomised evidence behind them that this gummy does not.
Everything above is true and none of it makes the product pointless. What it is for, and what its own label is allowed to say it supports, is set out on the benefits page.
Why nine JellyFil extracts in one blend is a design choice
A formulator picking nine extracts for one gummy is not trying to deliver nine trial doses. Nine names read as comprehensive on a sales page, each one brings its own small body of tradition or research, and the combination is hard for a competitor to copy exactly. That is the commercial logic and it is worth understanding rather than being annoyed by.
The pharmacological logic is thinner. Nothing in the published record tests these nine together, at these proportions, in this format, so the combination is a formulator’s judgement rather than a tested unit. What can be said is that nothing here is exotic: the same names recur across this category, and the evidence review of it examined exactly this pattern in the best-selling products.
There is a real argument on the other side and this page will not pretend otherwise. Several of these extracts act on related systems, and small amounts of several things pushing the same way is a genuine idea rather than a marketing one. It is simply an untested idea at 82 mg, and a reader is entitled to weigh it as such.
Who publishes this JellyFil website?
Only the sources this page links to. Each one opens to a public record, and the amount every study used is printed beside its extract above.
- da Silva AL, Piato AL, Bardini S, et al. Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice. J Ethnopharmacol. 2004;95(2-3):199-203. PMID 15507336. https://pubmed.ncbi.nlm.nih.gov/15507336/
- Siqueira IR, Fochesatto C, da Silva AL, et al. Ptychopetalum olacoides, a traditional Amazonian “nerve tonic”, possesses anticholinesterase activity. Pharmacol Biochem Behav. 2003;75(3):645-50. PMID 12895682. https://pubmed.ncbi.nlm.nih.gov/12895682/
- Kletter C, Glasl S, Presser A, et al. Morphological, chemical and functional analysis of catuaba preparations. Planta Med. 2004;70(10):993-1000. PMID 15490329. https://pubmed.ncbi.nlm.nih.gov/15490329/
- Gonzales GF, Córdova A, Vega K, et al. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. 2002;34(6):367-72. PMID 12472620. https://pubmed.ncbi.nlm.nih.gov/12472620/
- Shin BC, Lee MS, Yang EJ, et al. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med. 2010;10:44. PMID 20691074. https://pubmed.ncbi.nlm.nih.gov/20691074/
- Fornalik M, Malkiewicz A, Adamczak D, et al. Hormonal Modulation with Withania somnifera: Systematic Review and Meta-Analysis of Randomized-controlled Trials. Planta Med. 2026;92(8):790-805. PMID 41740946. https://pubmed.ncbi.nlm.nih.gov/41740946/
- Akhgarjand C, Asoudeh F, Bagheri A, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115-4124. PMID 36017529. https://pubmed.ncbi.nlm.nih.gov/36017529/
- Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9. PMID 17662090. https://pubmed.ncbi.nlm.nih.gov/17662090/
- Khalaf D, Krüger M, Wehland M, et al. The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure. Nutrients. 2019;11(7):1679. PMID 31336573. https://pubmed.ncbi.nlm.nih.gov/31336573/
- Suharyani S, Amanda B, Angellee J, et al. Tribulus terrestris for management of patients with erectile dysfunction: a systematic review and meta-analysis of randomized trials. Int J Impot Res. 2026;38(1):11-18. PMID 40360723. https://pubmed.ncbi.nlm.nih.gov/40360723/
- Khalesi S, Sun J, Buys N, et al. Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr. 2014;53(6):1299-311. PMID 24861099. https://pubmed.ncbi.nlm.nih.gov/24861099/
- Shindel AW, Xin ZC, Lin G, et al. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med. 2010;7(4 Pt 1):1518-28. PMID 20141584. https://pubmed.ncbi.nlm.nih.gov/20141584/
- Anand Ganapathy A, Hari Priya VM, Kumaran A. Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review. J Ethnopharmacol. 2021;267:113536. PMID 33137431. https://pubmed.ncbi.nlm.nih.gov/33137431/
- Kuchakulla M, Narasimman M, Soni Y, et al. A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements. Int J Impot Res. 2021;33(3):311-317. PMID 32358510. https://pubmed.ncbi.nlm.nih.gov/32358510/
Order JellyFil with the mechanism understood
Three pathways, nine extracts, one blend figure, and no claim on this website that the label does not support.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order JellyFil From This ShopLot JEL-26/JE-2310 · one a day, 30 to a bottle · ships from the United States